Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Nanoparticle systems make cancer treatment less toxic.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New cancer treatments aim to reduce side effects and improve effectiveness.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Promising cancer treatments were found, but the manufacturer closed.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.